Biophysical Assays, Drug Development and Fragment Screening

Search:

DAY

WEEK

MONTH

YEAR

Select your country:
Sign up | Log in

Biophysical Assays

Drug Development

Fragment Screening

Advancements in hit identification for membrane protein drug discovery

Drug Target Review

APRIL 7, 2025

GPCRs are critical targets for drug development due to their involvement in numerous disease pathologies, with many medications working by either activating or inhibiting these receptors. This stability enables the application of hit identification approaches such as fragment-based screening (FBS). doi:10.1016/j.apsb.2022.02.002.

Fragment Screening

Fragment Screening Drugs Biophysical Assays Small Molecule

Target-directed cancer: protein-ligand interactions

Drug Target Review

NOVEMBER 1, 2023

In terms of compound libraries, we have a high-throughput screening library of about 200,000 ligands. For fragment screening, which are much smaller compounds, we have a library of about 3000 fragments. We can screen with many different formats and modalities.

Fragment Screening

Fragment Screening Biochemical Assays Small Molecule Biophysical Assays

Drug Discovery Digest

Advancements in hit identification for membrane protein drug discovery

Target-directed cancer: protein-ligand interactions

Stay Connected